SCHEMBL177443

SCHEMBL177443

CC1(C)OCC(N)CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11567330 0.75
SCHEMBL15256782 0.73
SCHEMBL8634228 0.73 MEN1 (0.33)
SCHEMBL265168 0.71
SCHEMBL1947771 0.71
SCHEMBL9807214 0.71
SCHEMBL4656234 0.71
SCHEMBL9807213 0.71
SCHEMBL4656389 0.71
SCHEMBL9987398 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019020466-A1 PROCESS FOR THE HYDROLYSIS OR ALCOHOLYSIS OF CYCLIC KETAL OR ACETAL GROUPS WITH CARBON DIOXIDE OR AN ALCOHOL BASF SE (DE) 2019-01-31 WO claimed
EP-0643055-B1 Proces for the preparation of 5-amino-2,2-dialkyl-1,3-dioxanes ZAMBON SPA (IT) 1997-10-08 EP claimed
US-5580993-A Process for the preparation of iopamidol and 5-amino-2,2-dialkyl-1,3-dioxanes ZAMBON GROUP S.P.A. (IT) 1996-12-03 US claimed
EP-0643055-A1 Proces for the preparation of 5-amino-2,2-dialkyl-1,3-dioxanes ZAMBON GROUP S.p.A. (IT) 1995-03-15 EP claimed
EP-4735449-A1 TETRACYCLIC COMPOUNDS CONTAINING A FUSED INDOLE FOR TREATING APOL1-MEDIATED CHRONIC KIDNEY DISEASE OmniAB, Inc. (US) 2026-05-06 EP disclosed
US-20250296971-A1 GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS 3B PHARMACEUTICALS GMBH (DE) 2025-09-25 US disclosed
WO-2025137277-A1 DEGRADABLE PEPTOIDS NUTCRACKER THERAPEUTICS, INC. (US) 2025-06-26 WO disclosed
WO-2025006262-A1 TETRACYCLIC COMPOUNDS CONTAINING A FUSED INDOLE FOR TREATING APOL1-MEDIATED CHRONIC KIDNEY DISEASE OMNIAB, INC. (US) 2025-01-02 WO disclosed
US-12171756-B2 NLRP3 modulators INNATE TUMOR IMMUNITY, INC. (US) 2024-12-24 US disclosed
EP-4455159-A1 GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS WITH BIO-DISTRIBUTION MODIFIER 3B Pharmaceuticals GmbH (DE) 2024-10-30 EP disclosed
CN-118632858-A Gastric inhibitory peptide receptor ligands 3B制药有限公司 2024-09-10 CN disclosed
EP-4423110-A2 GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS 3B Pharmaceuticals GmbH (DE) 2024-09-04 EP disclosed
EP-0185130-B1 5-ALKOXY-2,4,6-TRIODO OR TRIBROMO-ISOPHTHALIC-ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND X-RAY CONTRAST AGENTS CONTAINING THEM BRACCO INDUSTRIA CHIMICA Società per Azioni (IT) 1988-03-02 EP disclosed
EP-0185130-A1 5-Alkoxy-2,4,6-triodo or tribromo-isophthalic-acid derivatives, process for their preparation and X-ray contrast agents containing them BRACCO INDUSTRIA CHIMICA Società per Azioni (IT) 1986-06-25 EP disclosed
EP-0026281-B1 2,4,6-TRIIODO-ISOPHTHALIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND X-RAY CONTRAST AGENTS CONTAINING THEM BRACCO INDUSTRIA CHIMICA Società per Azioni (IT) 1982-12-15 EP disclosed
US-4352788-A ARTERIES BRACCO INDUSTRIA CHIMICA S.P.A. (IT) 1982-10-05 US disclosed
US-4347359-A CEPHALOSPORIN INTERMEDIATES RHONE-POULENC INDUSTRIES (FR) 1982-08-31 US disclosed
EP-0026281-A1 2,4,6-Triiodo-isophthalic acid derivatives, process for their preparation and X-ray contrast agents containing them BRACCO INDUSTRIA CHIMICA Società per Azioni (IT) 1981-04-08 EP disclosed
US-4139605-A A, W-BIS(5-(DIHYDROXYALKYL)AMINOCARBONYL-3-HYDROXYACYLAMINO-2,4,6 -TRIIODOBENZOYLAMINO)-OXAALKANE BRACCO INDUSTRIA CHIMICA S.P.A. (IT) 1979-02-13 US disclosed
US-4001323-A RADIOPAQUE MATERIALS SAVAC AG (CH) 1977-01-04 US disclosed